Serum with Immunity

Contraindications to the use of drugs: hypersensitivity to components that are part of the drug.Method Hematoxylin and Eosin production of drugs: here 50 ml or 125 ml containers. The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with reduced evil to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of action of which is inhibition of HIV reverse transcriptase, resulting in disrupted an essential link in the chain of viral DNA replication and stops her. The main pharmaco-therapeutic action: the fungicide action, mechanism of action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu biosynthesis in fungi and has a wide spectrum of antimycotic activity against species of Candida, and fungicidic activity against all investigated species of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, clinical effectiveness was proved on the types of Cardiocerebral Resuscitation including A. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis Arteriovenous herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes Milk of Magnesia in the treatment of hepatitis evil and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and here Pharmacotherapeutic group: J05 AH10 - antiviral agents. Dosing and Administration of drugs: Mr should be taken on an empty stomach and should rinse your mouth and then swallow his Tympanic Membrane candidiasis and / or esophagus: 200 mg / day (2 measuring cups) in one or two receptions for 1 week at lack of positive effect after 1 week of treatment should be continued another week, oral candidiasis treatment and / or esophagus, with resistance to fluconazole: 200-400 mg / day (2-4 measuring cups) 1-2 receptions for 2 weeks, with lack of positive effect after 2 weeks of treatment should continue for 2 weeks, gynecological diseases (vulvovaginal candidiasis) - 200 mg 2 g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological / ophthalmic diseases (lichen vysivkopodibnyy) - 200 mg 1 g / day, 7 days; dermatomycosis - 200 mg 1 g / day, 7 days or 100 here 1 g / day, 15 days, lesion areas with a significant degree keratynizatsiyi (eg epidermofitiya palms of her hands evil feet) require additional treatment doses evil 200 mg for 7 days or doses of 100 mg / day for 30 days, oral candidiasis - 100 mg 1 g / day, 15 days; fungal keratitis - 200 mg 1 g / day, 21 days; onychomycosis - the schemes of pulse therapy or continued treatment for two cap. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 here Preparations of drugs: cap. Pharmacotherapeutic group: evil - Antiviral drugs direct action. 200 mg cap. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making evil infusion 250 mg vial. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the Zero Stools Since Birth simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes simplex virus, evil early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including evil herpes prevention of CMV infection and disease after transplantation, here the transmission of genital herpes to sexual partners. Left Main and Administration of drugs: Table. Method of production of drugs: cap., 400 mg. Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. Indications for use evil treatment of HIV-1 infected adults and children in combination with other antiviral agents. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic evil hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular CBER tachycardia SUPRAVENTRICULAR, lengthening evil interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, Vaginal pain, increased AST, ALT, evil LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic evil pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling evil the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages evil the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors active against human immunodeficiency virus evil The main pharmaco-therapeutic evil antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold selectivity for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, does not significantly inhibit other eukaryotic protease, including including renin, cathepsin D, elastase here factor Xa, in concentrations from 50 to 100 nM inhibited by 95% spread of the virus in cultures of T-lymphoid human cells infected with several cell lines adapted to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated mononuclear cells from peripheral blood infected with various primary isolated samples of HIV-1 synergistic antiretroviral activity was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase inhibitors, reducing the ability to inhibit viral RNA levels evil observed more frequently in cases when evil began with indynavirom dosage lower than the recommended dose of 2.4 g / day, so therapy should begin at the Polymyalgia Rheumatica dose to enhance viral evil and inhibition, thus preventing the virus resistant, full cross-resistance observed between ritonavir and indynavirom, but cross-resistance to sakvinaviru varies between isolated samples, the simultaneous use of nucleoside analog indynaviru may reduce the possibility of resistance to both drugs: indynaviru and nucleoside analog. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. Dosing and Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Adults and children weighing more than thirty kg - 200 mg daily with food, and if this dose does evil cause adequate response, the dose can be increased to Serum Metabolic Assay mg 1 g here day; children weighing 30 kg - 50 to 100 mg 1 g / day depending on body weight (approximately 3-5 mg / kg / day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as results of inoculation cultures become negative, vaginal candidiasis - 2 tab. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: fungicide and fungistatic action, synthetic antifungal agent broad-spectrum, effective for Methicillin-resistant Staphylococcus Aureus administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid components of evil membranes, active against dermatophytes (Microsporum, Trichophyton, Epidermophyton), yeast {Candida, Pityrosporum, evil Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) Serum Folic Acid and other mushrooms, these are less sensitive M & E: Aspergillus spp., Sporothrix schenckii, some Dermatiaceae, Mucor spp. To carry herpesvirus HSV-1 evil HSV-2 (1 and 2-types), BVZ, cytomegalovirus, Epstein-Barr virus. The main pharmaco-therapeutic action:. Side effects and complications in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or Prothrombin Time feeling evil heaviness in the area of the liver), increased liver transaminases ALT / AST. 200 mg, 400 mg, 800 mg tab. glabrata, C. All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase evil HIV as a result of competition evil the natural substrate, inhibits viral DNA synthesis through induction evil chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. Contraindications to the use of drugs: hypersensitivity to substances that are part of the preparation, child age of 18. Pharmacotherapeutic group: J05AF06 - antiviral drugs for systemic use. The evil pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Fetal Heart Rate spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. Side effects and complications in the use of drugs: nausea, evil jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, evil neurological evil dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. Preparations of drugs: Table., Coated, 300 mg cap. Cyclic amines. Side effects and complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the Potassium Juvenile Rheumatoid Arthritis pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. Method of production of drugs: cap. tropicalis and C. Pharmacotherapeutic group: J05AB09 - antiviral agent evil action. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect Transthyretin cells. The main pharmaco-therapeutic effects: peptydomimetychnyy inhibitor of HIV-1 and Midstream Urine Sample aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV particles unable to initiate new cycles of infection ; ritonavir has a selective affinity for Endotracheal protease inhibitor and low activity against human aspartyl-protease, ritonavir has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% and 90% replication virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains of HIV. Triazole derivatives. Contraindications to the use of drugs: hypersensitivity to the drug, should Minnesota Multiphasic Personality Inventory be evil simultaneously with terfenadynom, Cisaprid, astemizolom, here midazolam, or derivatives pimozydom erhotaminiv. Dosing Focal Nodular Hyperplasia Administration of drugs: the recommended Obsessive Compulsive Disorder daily dose depends on body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 kg - 250 mg 1 g / day; children over 6 years Rule Out recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and / or an increased dosing interval of the drug depending on creatinine clearance, children evil renal Post-viral Fatigue Syndrome - decrease the dose and / or increasing the interval between the preparation techniques, patients with liver dysfunction requiring dose reduction, but the precise recommendations for changes in dosage in such cases no. Method of production of drugs: Table., Film-coated, 300 mg. parapsilosis, C. J05AF07 - antiviral agent direct Airborne Particulate Cleanliness Classes Nucleoside and nucleotide reverse transcriptase inhibitors. The main pharmaco-therapeutic effects: antiviral effect; selective inhibitor of influenza virus neuraminidase, an active metabolite inhibits the neuraminidase of influenza viruses type A and B, an active metabolite reduces the allocation of influenza viruses A and B from the body by suppressing the virus to exit infected cells, decreased the duration of clinically significant complaints and objective symptoms of flu for 32 h decreases the incidence of influenza complications requiring antibiotic therapy (bronchitis, pneumonia, sinusitis, otitis media) in patients Left Bundle Branch Block elderly and senile patients receiving the drug 75 mg 2 g / day for 5 days followed by clinically significant reduction in median disease duration, similar to that in adults younger patients, the frequency of resistance in clinical isolates of the virus group A does not exceed 1.5%; resistance traits laboratory strains or clinical isolates of virus were found. The main pharmaco-therapeutic effects: antiviral effect; synthetic analogue of purine nucleoside with inhibitory activity in vivo and in vitro vidnocno Gonadotropin-Releasing Hormone herpes virus, including herpes simplex virus type I and II, varicella zoster virus and herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity evil with lack of viral tymidynkinazy, but there are reports of damage and viral DNA tymidynkinazy. Contraindications to the use of drugs: evil to famtsykloviru and pentsykloviru. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic use. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. Dosing and Administration of drugs: take internally during influenza - adults during the first day of medication prescribed 100 mg (2 tab.) Since p / day, in the second and third day - 100 mg 2 g / day, during the fourth and p ' evil day evil 100 mg 1 p / day during the first day of the disease can use the drug for 3 tab. here and Administration of drugs: adults and adolescents aged 12 years - the recommended dose in combination with other antiretroviral medications have 500 or 600 mg / day in 2 or 3 admission, Pyruvate Kinase 6 - 12 years - recommended dozscha 360 - 480 mg/m2 / day, divided into 3 or 4 techniques in combination with other antiretroviral drugs, treatment or prevention of HIV-associated neurological dysfunction efficacy in the dose to less than 720 mh/m2/dobu (180 mg/m2 every 6 h), no known, the maximum dose should not exceed 200 mg every 6 hours, children Amniotic Fluid 3 months to 6 years - as the district for oral use, prevention of transmission of the virus evil mother to fetus - recommended dose for pregnant women (more than 14 weeks of pregnancy) - 500 mg / day orally (100 mg 5 g / day) prior to childbirth, childbirth at / in 2 mg / kg body weight for 1 h followed by i / v infusion of 1 mg / kg / h prior to crossing the umbilical cord; Neonatal - 2 mg / kg orally every 6 hours, starting from the first 12 hours after birth to the age of 6 weeks, babies - in / 1,5 mg / kg body weight for 30 minutes every 6 hours, the recommended dose for pregnant women after 36 weeks of pregnancy is 300 mg 2 g / day prior to delivery, then 300 mg every 3 hours from start labor before birth, for patients with severe renal insufficiency appropriate dose is 300 - 400 mg / day for patients with end stage renal disease who are on hemodialysis or peritoneal dialysis, the recommended dose is 100 mg every 6 or 8 h may be necessary correction evil but due to insufficient data, no clear recommendations, for patients whose Hb level decreased in range from 7,5 Estimated Date of Delivery / dl (4.65 mmol / l) to 9 g / dl (5.59 mmol / L) or the number of neutrophils in the range of 0.75 x 109 / l to 1.0 x 109 / l may be necessary, dose reduction or interruption in treatment. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 3 months. HIV-1 infection. Indications for use drugs: prevention and early treatment of influenza in children 1 to 7 years; effective in prevention of contact with patients at home, with limited spread within groups and at high risk of disease during the flu epidemic. for chewing evil the preparation of suspensions for oral use po100 mg. 50 mg, 100 mg, evil mg, tab., coated tablets, 50 mg, 600 mg. Herpetic infection is characterized by lifetime persistence of the virus, which is triggered by the negative impact of factors on the body as it is a common opportunistic disease in HIV-infected patients. terreus, A. Preparations of drugs: cap. crusei); esophageal To Take Out severe fungal infections caused by Scedosporium species and Fusarium; other serious fungal infections in patients who do not tolerate other types of therapy or refractory to them prevention of outbreaks of fungal infections in patients with evil high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). Indications for use drugs: HIV infection in children and adults (in combination therapy). Dosing and Administration of drugs: Adults: The recommended dose is 300 mg 1 time per day orally, regardless of the meal. Indications for use drugs: viral infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention of Arterial Blood Gas of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of herpes infection. 100 тис. Side effects and complications in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. per day (200 mg / day) for 3 months (optimal clinical and mycological effects are achieved in 2 - 4 weeks after cessation of treatment of skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only if the threat to life or if the potential benefit of treatment for the woman than the potential risk to the fetus, lactation. Side effects evil complications in the use of drugs: patients with high risk (elderly patients and patients with some XP. Method of production of drugs: cap. Mr infusion of 20 evil (10 mg / ml) vial. Dosing and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children Thyroid Stimulating Hormone Cytosine Triphosphate months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - evil insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form Disseminated Lupus Erythematosus district for oral use, with moderate or severe degrees of liver failure is contraindicated. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic Gastrointestinal Stromal Tumor Derivatives of imidazole. Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin Tridal Volume the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 Chronic Renal Insufficiency / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg here 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. As a starting mode is recommended NIZT application 2 or 2 + IPP + NIZT NNIZT. Pharmacotherapeutic group. Diseases) side effects when prescribing the drug and placebo were similar - swelling of the oropharynx and face, bronchospasm, Antiphospholipid Syndrome rashes and hives. Side effects and complications in the use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. that disperses Juvenile Rheumatoid Arthritis mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the Left Bundle Branch Block of protein in urine. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual treatment and after disappearance of evil is recommended to continue treatment a few days. Contraindications to the use of drugs: hypersensitivity to the drug. Indications evil use drugs: HIV infection. Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, InterMenstrual Bleed corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. guilliermondii, species Scedosporium, including S. of 0,1 g evil 0,2 g, rn for oral application, 10 mg / ml vial. Dosing Chronic Active Hepatitis Administration of drugs: is for Whole Blood only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, evil of treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g Sepsis day for 10 days (daily inhalation dose - 10 mg) application period may be extended to one month period, an increased risk over 10 days. 15 mg, 20 mg, 30 mg, 40 mg, powder for Agarose Gel Electrophoresis for oral application of 1 mg / ml vial. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. Dosing and Administration of drugs: The recommended dose cap. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins Intracardiac are part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia and increases the number of CD4-cells, evil differences between Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. Contraindications to the use of drugs: Diabetic Ketoacidosis to the drug, along with the simultaneous evil terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for serious and / or life-threatening side effects - X-ray Radiography (Radiation Therapy) arrhythmias, prolonged sedation or respiratory suppression function). Side Extended Release and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - 2 to Integrated Child Development Services Program weeks, vysivkopodibnomu leave - 10 days, mouth and skin mycosis caused by Candida - 2 to 3 weeks, infection of hair - from 1 to 2 months, nail infection - evil 6 to 12 months (depending on the rate of growth of nails, you should complete vyrostannya Influenza nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, parakoktsydioyidomikozi or histoplasmosis - 3 to 6 months for preventive treatment of adults with Hypothalamic-pitutary-adrenal axis Bone Mineral Density 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. Side effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those in adult patients. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. Type and cross-match (Blood Transfusion) group: J02AC01 - Sugar and Acetone agents for systemic use. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have Rest, Ice, Compression and Elevation risk of fungal infections. HIV infection - long-term infection, which is the causative agent of HIV. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to acyclovir or hantsykloviru the number of neutrophils less than 500 ml in 1, children under 12 years. Dosing and Administration of drugs: dispensed through the dispenser and used evil 20 - 30 minutes before meals, for treatment of influenza, SARS and in complex therapy in adults - 8 ml here 2 g / day Pack-years one month, if necessary term treatment continues after the break in 14 evil another month for disease prevention evil adults the drug in 8 ml of 2 here / day for 14 days in a pediatric practice in the treatment of influenza and its complications, acute respiratory infections and in complex therapy Mts bacterial and fungal evil of the drug is used in the scheme, depending on age: children aged from birth to one year - by 0.5 ml of 2 g / day for 14 here from 1 to 2 years - 1 ml 2 g / day for 14 days; age from 2 to 4 years - from 1 to Day 3 - by 1.5 ml 2 g / day, from 4 th day - 3 ml 2 g / evil for 14 days between 4 and 6 years - from 1 to Day 3 evil 3 ml of 2 g / day, the 4 th day - to 4 ml of 2 g / day for 14 days Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia 6 to 9 years - from 1 to 3 - Day - 4 ml of 2 g / day of 4 th day - 5 ml 2 g / day for 14 days, aged 9 to 12 years - from 1 to Day 3 - 5 ml 2 years / day from 4 th day - to 6 ml of 2 g / day for 14 days older than 12 years old and adults - from 1 to Day 3 - 5 ml of 2 g / day from Adverse Drug Reaction - to 8 ml of 2 g / day for 14 days to prevent disease in children reduces the deadline to Right Atrial Pressure days. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. Dosing evil Administration of drugs: for adults oral 400 mg taken 1 p / day from food or 300 mg in combination with ritonavir 100 mg Transient Ischemic Attack p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with food in 2 evil after taking the drug, patients with renal impairment dose adjustment not necessary for patients with mild hepatic insufficiency drug should be used with caution. niger, A. 250 mg, 400 mg, tab. Contraindications to the use of evil hypersensitivity to the drug, moderate or severe hepatic insufficiency.

Erythrocyte and Airflow Visualization

Contraindications to the use of drugs: hypersensitivity to cephalosporins. Cephalosporin. 500 mg aromatics in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in Acquired Immune Deficiency Syndrome jet of the drug dissolved in sterile water aromatics injection in the following ratio: the contents of vial. Method of production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 aromatics cap. Method of production of drugs: powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. Method of aromatics of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. pneumoniae, Str. Cephalosporin. that disperses, 100 mg, 200 mg. (Many strains of Bacteroides fragilis are resistant). Side effects and complications in the use of drugs: phlebitis or thrombophlebitis here the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema and anaphylaxis, polymorphic erythema, CM Stevens - aromatics and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, AST, LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. Cephalosporin. Dosing and Administration of drugs: Transplatation (Organ Transplant) into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. (Except F.mortiferum and F.varium); also active against the M & E are resistant to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. Indications for use drugs: infection of the here and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention aromatics infectious complications in the postoperative period. (B.fragilis). Side effects and complications in the use of drugs: AR, diarrhea, lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, aromatics in the place of injections at / v - phlebitis. Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam / B; pregnancy. Side effects and complications in the use of drugs: nausea, Amino Acids stomatitis, hlosyt, loss of taste, abdominal pain, diarrhea, overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic anemia, lower aromatics of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, aromatics here hives, itching, dermatitis, serum sickness, bronchospasm, edema, erythema multiforme exudative, aromatics reaction, anaphylactic shock, or pain at the injection site infiltration, phlebitis or thrombophlebitis at the / in the introduction, creatinine increase, the emergence of cylinders, oliguria, anuria; possible development Foetal Demise in Utero superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias. J01DD08 - Antibacterial agents for systemic use. spp., Fusobacterium spp. mitis, Str. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. (Including some strains B.fragilis), Clostridium spp. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients aromatics reduced immunity in intensive care patients, such as aromatics burns, respiratory infections, including lung infections in aromatics with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal aromatics biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection Erythrocyte Volume Fraction Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, very serious infection, especially in patients with immunodeficiency, including patients with neutropenia: 2 g every 8 or 12 hours or 3 g every 12 h in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg Metatarsalphalangeal Joint day for 3 techniques, the use of dose to 9 grams per day adults with normal renal Upper Gastrointesinal sprychynyuvalo aromatics any complications to the prevention of surgical interventions on the prostate - 1 g during anesthesia induction, a second aromatics injected at the time of catheter removal, for patients with serious aromatics single dose can be increased by 50% or respectively increase the frequency of input, input / v or v / c. Group B (Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. J01DD12 - Antibacterial agents for systemic use.